![]()
|
|
|
Registries for All Diseases named Sanofi US' Collaborate Activate Innovation Challenge winner
12-13-2012
SHARING OPTIONS:
BRIDGEWATER, N.J.—Sanofi US has named Registries for All
Diseases as the winner of the Collaborate Activate Innovation Challenge. As a
result, Registries for All Diseases will be awarded $300,000 for the creation
of a crowd-sourced, cross-disease registry to aid in accelerating translational
research in over 1,000 diseases. The team is made up of partnering
organizations Genetic Alliance, CFIDS Association of America, National
Psoriasis Foundation and the Inflammatory Breast Cancer Research Foundation. All
told, the Registries for All Diseases team plans to reach over 9,000 health
organizations and 1,200 disease advocacy organizations.
"Collaborate Activate embodies our commitment to
improving health outcomes for patients by uniting the advocacy community to
accelerate innovation," Anne Whitaker, president of North America
Pharmaceuticals at Sanofi US, said in a press release. "Registries for All
Diseases exemplifies the collaborative nature of the challenge by creating a
multi-tiered solution that captures both common data across all diseases and
disease-specific data, showcasing the expertise of each partnering
organization."
Collaborate Activate is one of the initiatives of Sanofi’s
Partners in Patient Health, and was announced this May. The challenge called
for two or more groups to collaborate in order to qualify and was intended to
promote the sharing of complementary resources between partnering
organizations. Sanofi US created the challenge in hopes that uniting patient
advocates would lead to novel ideas that would not be possible otherwise.
"Data can accelerate research and services, help us get
better patient outcomes, and save money," Sharon Terry, president and CEO
of Genetic Alliance, said in a statement. "But right now, this data is in
silos and is not easily accessible to researchers. By creating a
patient-centered research network that spans many diseases, people will be
empowered to participate in their own health and can contribute data to advance
the development of disease treatments."
Registry for All Diseases was one of four teams that made it
to the final phase of Collaborate Activate, and each finalist received $25,000
and mentorship from Sanofi team members and healthcare experts in order to
fine-tune their ideas before presenting to the judging panel. Submissions were
received from a total of 280 partnering organizations for new solutions in
enabling patients to engage in their health.
"Creating a registry of patients is the single most
valuable action a rare disease community can take," said David Meeker, MD,
President and CEO of Genzyme, a Sanofi company. "The registry provides
critical disease knowledge which makes that disease easier to study, increasing
the probability a treatment can be developed. We congratulate the Registries
for All Diseases team."
The second place winner in the Collaborate Activate
Innovation Challenge is 21st Century Brain Trust, consists of the Geoffrey
Beene Gives Back Alzheimer's Initiative, the American Health Assistance
Foundation and the USAgainstAlzheimer’s Network, and will receive $100,000 to
develop its solution, a self-administered, clinical-grade cognitive testing app
meant for the detection of asymptomatic Alzheimer’s disease. The app is
intended to anticipate the onset of Alzheimer’s as well as establishing a
dialogue focused on brain health rather than brain disease, prompting people to
take control of their own cognitive well-being.
SOURCE: Sanofi US press release Code: E12131201 Back |
|
||
|
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|